Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues
Reexamination Certificate
2011-06-21
2011-06-21
Saoud, Christine J (Department: 1646)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
C530S351000, C530S323000, C435S975000
Reexamination Certificate
active
07964703
ABSTRACT:
Nucleic acids encoding mammalian, e.g., primate, receptors, purified receptor proteins and fragments thereof. Antibodies, both polyclonal and monoclonal, are also provided. Methods of using the compositions for both diagnostic and therapeutic utilities are described.
REFERENCES:
patent: 5888774 (1999-03-01), Delcuve
patent: 6495667 (2002-12-01), Bazan
patent: 6756481 (2004-06-01), Chirica et al.
patent: 2003/0009018 (2003-01-01), Meada et al.
patent: 2003/0082734 (2003-05-01), Dowling et al.
patent: 2005/0106673 (2005-05-01), Dowling et al.
patent: 1 221 482 (2002-07-01), None
patent: 1 221 482 (2005-12-01), None
patent: 273358 99 (1999-09-01), None
patent: WO 01/23556 (2000-09-01), None
patent: WO 00/73451 (2000-12-01), None
patent: WO 01/18051 (2001-03-01), None
Aggarwal, et al., (Jan. 17, 2003)J. Biol. Chem.278(3):1910-1914, “Interleukin-23 promotes a distinct CD4 T cell activation state characterized by production of interleukin-17”.
Barrett, (Mar. 1996)Baillieres Clin. Gastroenterol.10(1):1-15, “Cytokines: sources, receptors and signalling”.
U.S. Appl. No. 09/322,913, filed Jun. 1, 1999, Dowling et al.
U.S. Appl. No. 60/203,426, filed May 10, 2000, Chirica et al.
Bazan, et al., (Feb. 1996)Nature379:591, “A newly defined interleukin-1?”.
Becker, et al., (Sep. 2003)J. Clin. Invest.112:693-706, “Constitutive p40 promoter activation and IL-23 production in the terminal ileum mediated by dendritic cells”.
Briscoe, et al., (Feb. 1996)Philos. Trans. R. Soc. Lond. B Biol. Sci.351(1336):167-71, “JAKs, STATs and signal transduction in response to the interferons and other cytokines”.
Chaiken and Williams (Oct. 1996)Trends Biotechnol., 14(10):369-75, “Identifying structure-function relationships in four-helix bundle cytokines: towards de novo mimetics design”.
Cooper, et al., (2002)J. Immunol., 168:1322-1327, “Mice lacking bioactive IL-12 can generated protective, antigen-specific cellular responses to mycobacterial infection only if the IL-12 p40 subunit is present”.
Cua, et al., (Feb. 13, 2003)Nature, 421:744-748, “Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain”.
Gately et al. (1998)Ann. Rev. lmmunol.16:495-521 “The Interleukin-12/Interleukin-12-Receptor System: Role in Normal and Pathologic Immune Responses”.
Gonda and D'Andrea (Jan. 1997)Blood89(2):355-369 “Activating mutations in cytokine receptors: implications for receptor function and role in disease”.
Happel, et al., (2003)J. lmmunol.170:4432-4436, “Cutting edge: roles of toll-like receptor 4 and IL-23 in IL-17 expression in response toKlebsiella pneumoniaeinfection”.
Heinrich, et al., (Sep. 1998)Biochem. J.334(Pt 2):297-314 “Interleukin 6-type cytokine signalling through the gp130/Jak/STAT pathway”.
Herz, et al., (Sep. 1997)J. Recept. Signal Transduct. Res.17(5):671-776 “Molecular approaches to receptors as targets for drug discovery”.
Hibi, et al., (Jan. 1995)GenBank, Accession No. M57230 Definition: Human membrane glycoprotein gp130 mRNA, complete cds.
Hölscher, et al., (2001)J. Immunol.167:6957-6966, “A protective and agonistic function of IL-12p40 in mycobacterial infection”.
Ihle, et al. (1997)Stem Cells, 15(Suppl 1):105-11, “Jaks and Stats in cytokine signaling”.
Krajina, et al., (2003)Eur. J. Immunol.33:1073-1083, “Colonic lamina propria dendritic cells in mice with CD4+T cell-induced colitis”.
Levy (Mar. 1997)Cytokine Growth Factor Rev., 8(1):81-90, “The house that JAK/STAT built”.
Lok, et al., (Sep. 1999)Database EMBL Online!, Accession No. AF178684, Definition: Homo sapiens class I cytokine receptor (zcytor5) mRNA, complete cds.
Mahairas, et al. (1999)Proc. Nat'l. Acad. Sci.(USA) 96:9739-9744, “Sequence-tagged connectors: A sequence approach to mapping and scanning the human genome”.
Ngo, et al. (1994) “The Protein Folding Problem and Tertiary Structure Prediction” pp. 492-495.
Opalinska and Gewirtz (2002)Nat. Rev. Drug. Disc.1:503, “Nucleic-acid therapeutics: basic principles and recent applications”.
Parham, et al., (2002)J. Immunol. 168:5699-5708, “A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rb1 and a novel cytokine receptor subunit, IL-23R”.
Patel, et al., (Nov. 1996)J Biol Chem. 271(48):30386-30391, “Functional replacement of cytokine receptor extracellular domains by leucine zippers”.
Pettit and Gombotz (1998)Trends in Biotech. 16:343-349, “The development of site-specific drug-delivery systems for protein and peptide biopharmaceuticals”.
Phillips (2001)J. Pharm. and Pharmacology53:1169-1174, “The challenge of gene therapy and DNA delivery”.
Presky, et al., (Nov. 1996)Proc. Natl. Acad. Sci. USA, 93:14002-14007, “A functional interleukin 12 receptor complex is composed of two b-type cytokine receptor subunits”.
Presky, et al., (Nov. 2000)GenBank, Accession No. U64198, Definition: Human IL-12 receptor beta2 mRNA, complete cds.
Scott, et al. (1999)Nature Genetics21:440-443, “The Pendred syndrome gene encodes a chloride-iodide transport protein”.
Silvennoinen, et al., (Jul. 1997)APMIS105(7):497-509 “Cytokine receptor signal transduction through Jak tyrosine kinases and Stat transcription factors”.
Uhlig and Powrie (Sep. 2003)J. Clin. Invest.112(5)648-651, “Dendritic cells and the intestinal bacterial flora: a role for localized mucosal immune responses”.
Waldvogel, Database EMBL Online!, Accession No. AJ308426, Feb. 5, 2001.
Wang, et al. (1992)Genomics14(3):666-672, “Molecular cloning and characterization of the rat liver IL-6 signal transducing molecule, gp130”.
Winston and Hunter (Jun. 1996)Current Biology6(6):668-671 “Intracellular signalling: Putting JAKs on the kinase MAP”.
Wells (1990)Biochemistry29(37):8509-8517, “Additivity of Mutational Effects in Proteins”.
Wiekowski, et al., J. Immunol., 166:7563-7570 (2001), “Ubiquitous transgenic expression of the IL-23 subunit p19 induces multiorgan inflammation, runting, infertility, and premature death.”
Wu et al. (1996)Eur. J. Immunol. 26:345-350 “Biological function and distribution of human interleukin-12 receptor β chain”.
http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=601604, Dec. 7, 2009.
Notice of Opposition to a European patent for Patent No. EP 1 287 130, Application No. 01935242.6, “Mammalian Cytokine Receptor Subunit Proteins, Related Reagents and Methods.” Patent Application Applicant is Schering Corporation, Feb. 20, 1999.
Patentee's Response to Notice of Opposition re EP Patent 1 287 130, Oct. 6, 2009.
Main and Auxiliary Claim Requests re EP Patent 1 287 130, Oct. 6, 2009.
Preliminary Opinion of the Opposition Division in the opposition of EP 1287130 B1 (EPO Form 2906) dated Jul. 27, 2010.
Waterston,Database EMBL Online!, Accession No. AC26054, Mar. 20, 2000. Definition: Homo sapiens chromosome 1 clone RP11-131015, working draft sequence, 26 unordered pieces.
Chirica Madaline
Kastelein Robert A.
Moore Kevin W.
Parham Christi L.
Bellomy Gregory R.
Saoud Christine J
Schering Corporation
Seharaseyon Jegatheesan
LandOfFree
DCRS5 polypeptides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with DCRS5 polypeptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and DCRS5 polypeptides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2707242